Q1 2022 13F Holders as of 3/31/2022
-
Type / Class
-
Equity / Common Stock, $0.01 par value per share
-
Shares outstanding
-
50.5M
-
Number of holders
-
620
-
Total 13F shares, excl. options
-
47.4M
-
Shares change
-
+533K
-
Total reported value, excl. options
-
$13.5B
-
Value change
-
+$106M
-
Put/Call ratio
-
1.56
-
Number of buys
-
306
-
Number of sells
-
-336
-
Price
-
$283.97
Significant Holders of CHARLES RIVER LABORATORIES INTERNATIONAL, INC. - Common Stock, $0.01 par value per share (CRL) as of Q1 2022
770 filings reported holding CRL - CHARLES RIVER LABORATORIES INTERNATIONAL, INC. - Common Stock, $0.01 par value per share as of Q1 2022.
CHARLES RIVER LABORATORIES INTERNATIONAL, INC. - Common Stock, $0.01 par value per share (CRL) has 620 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 47.4M shares
of 50.5M outstanding shares and own 93.86% of the company stock.
Largest 10 shareholders include VANGUARD GROUP INC (5.94M shares), BlackRock Inc. (5.23M shares), FMR LLC (2.39M shares), STATE STREET CORP (2.02M shares), KAYNE ANDERSON RUDNICK INVESTMENT MANAGEMENT LLC (1.64M shares), Clearbridge Investments, LLC (1.37M shares), MASSACHUSETTS FINANCIAL SERVICES CO /MA/ (1.14M shares), WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC (1.04M shares), GEODE CAPITAL MANAGEMENT, LLC (959K shares), and Invesco Ltd. (951K shares).
This table shows the top 620 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.